XML 62 R24.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Segment Information
6 Months Ended
Jun. 30, 2011
Segment Information  
Segment Information

Note 17—Segment Information

The Company currently operates within one "Specialty Pharmaceutical" segment which includes sales of KRYSTEXXA, Oxandrin and oxandrolone and the research and development activities of KRYSTEXXA.